secwatch.observer — SEC 8-K summary
======================================

Issuer:     CITIUS ONCOLOGY, INC. (CTOR)
CIK:        0001851484
Form:       8-K
Filed at:   2024-01-10T23:59:59+00:00
Accession:  0001493152-24-001958
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TenX Keane Acquisition files proxy supplement for extension; sponsor to fund trust for up to 10-month extension
--------------------------------------------------------------------------------

- Extraordinary general meeting on Jan 17, 2024 to vote on extension amendment.
- If approved, sponsor will contribute up to $200k or $0.10/share for first 3-month extension.
- For subsequent monthly extensions, sponsor contributes up to $66,667 or $0.03/share per month.
- Extensions could extend deadline from Jan 18, 2024 to as late as Nov 18, 2024.
- Loans are non-interest bearing and repayable upon business combination.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1851484/000149315224001958/0001493152-24-001958-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1851484/000149315224001958/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-001958

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer